News

The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and ...
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1 July 17, 2025 This is the fourth update of the full comprehensive update of the clinical ...